6-75886952-G-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004999.4(MYO6):c.2616G>T(p.Lys872Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000254 in 1,613,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004999.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 22Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, G2P
- autosomal recessive nonsyndromic hearing loss 37Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYO6 | NM_004999.4 | c.2616G>T | p.Lys872Asn | missense_variant | Exon 25 of 35 | ENST00000369977.8 | NP_004990.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYO6 | ENST00000369977.8 | c.2616G>T | p.Lys872Asn | missense_variant | Exon 25 of 35 | 1 | NM_004999.4 | ENSP00000358994.3 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152124Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000597 AC: 15AN: 251230 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461434Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727018 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000125 AC: 19AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74432 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Lys872Asn variant in MYO6 has not been previously reported in individuals with hearing loss, but has been identified in 7/10324 African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs139 542573). Although this variant has been seen in the general population, its freq uency is not high enough to rule out a pathogenic role. Lysine (Lys) at position 872 is not conserved in mammals or evolutionarily distant species, raising the possibility that a change at this position may be tolerated. Additional computa tional prediction tools suggest that the p.Lys872Asn variant may not impact the protein, though this information is not predictive enough to rule out pathogenic ity. In summary, the clinical significance of the p.Lys872Asn variant is uncerta in. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at